awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38650019-318CB145-09E6-4C11-AE77-5A107B370CA0
Q38650019-318CB145-09E6-4C11-AE77-5A107B370CA0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38650019-318CB145-09E6-4C11-AE77-5A107B370CA0
Addition of an antiangiogenic therapy, bevacizumab, to gemcitabine plus oxaliplatin improves survival in advanced biliary tract cancers.
P304
Q38650019-318CB145-09E6-4C11-AE77-5A107B370CA0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38650019-318CB145-09E6-4C11-AE77-5A107B370CA0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5679298188c2dc4702b536fd0108a6662f8cc8ed
P304
156-162
http://www.w3.org/2001/XMLSchema#string